30 December 2024 : Clinical Research
Hemorrhagic Risk in Vestibular Schwannoma Surgeries: Insights and Implications
Alper Tabanli1ABCDEFG*, Hakan Yilmaz




DOI: 10.12659/MSM.946583
Med Sci Monit 2024; 30:e946583
Table 3 Reoperation details, hospital stay, and follow-up for patients with and without postoperative hemorrhage/edema.
Characteristic | Value/hemorrhage/edema Group (n=7) | No hemorrhage/edema Group (n=23) | P-value |
---|---|---|---|
Patients requiring reoperation [n, (%)] | 5 (16.7%) | – | – |
Time to reoperation (mean days ±SD) | 12±4.5 | – | – |
Reason for reoperation | – | – | – |
– Intratumoral hemorrhage | 3 (60%) | – | – |
– Peritumoral edema | 2 (40%) | – | – |
Outcomes after reoperation [n, (%) for each GOS score] | – | – | – |
– GOS 5 (good recovery) | 2 (40%) | – | – |
– GOS 4 (moderate disability) | 1 (20%) | – | – |
– GOS 3 (severe disability) | 1 (20%) | – | – |
– GOS 1 (death) | 1 (20%) | – | – |
Median hospital stay [days (range)] | 29 (15–450) | 9 (5–47) | 0.01 |
ICU stay required [n, (%)] | 5 (71.4%) | 3 (13%) | 0.003 |
Median ICU stay (days, range) | 10 (3–30) | 5 (2–10) | 0.02 |
Patients requiring rehabilitation [n, (%)] | 4 (57.1%) | 4 (17.4%) | 0.04 |
Median follow-up time [months (range)] | 12 (6–24) | 18 (12–36) | 0.05 |
GOS – Glasgow Outcome Scale, ICU – Intensive Care Unit. |